Platelet-derived Growth Factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and bad phosphorylation

Journal of Biological Chemistry

Volumn 289, Issue 9, 2014, Pages 6225-6235

  Son, Dain ^a   Na, Yi Rang ^a   Hwang, Eung Soo ^a   Seok, Seung Hyeok ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED MACROPHAGES; ANTI-APOPTOTIC EFFECTS; BREAST CANCER CELLS; POLY POLYMERASE; SIGNALING PATHWAYS; SURVIVAL MECHANISMS; TUMOR PROGRESSIONS; TUMOR-ASSOCIATED MACROPHAGES;

CELL CULTURE; CELL DEATH; PHOSPHORYLATION; TUMORS;

MACROPHAGES;

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; PROTEIN BAD; PROTEIN KINASE B; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ISOLATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SUPERNATANT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

AKT; APOPTOSIS; BAD; BREAST CANCER; CASPASE; MACROPHAGES; PI 3-KINASE (PI3K); PLATELET-DERIVED GROWTH FACTOR-C (PDGF-C);

APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHOKINES; MACROPHAGES; MALE; NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIGNAL TRANSDUCTION; STAUROSPORINE;

EID: 84896867662     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.508994     Document Type: Article

References (82)

1. Heldin, C. H., Ostman, A., and Rönnstrand, L. (1998) Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta 1378, F79-F113 (Pubitemid 28381127)
2. Claesson-Welsh, L. (1994) Platelet-derived growth factor receptor signals. J. Biol. Chem. 269, 32023-32026
3. Hurst, N. J., Jr., Najy, A. J., Ustach, C. V., Movilla, L., and Kim, H. R. (2012) Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression. Biochem. J. 441, 909-918
4. Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., and Betsholtz, C. (1999) Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055 (Pubitemid 29378170)
5. Shimokado, K., Raines, E. W., Madtes, D. K., Barrett, T. B., Benditt, E. P., and Ross, R. (1985) A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 43, 277-286 (Pubitemid 16199714)
6. Badgett, A., Bonner, J. C., and Brody, A. R. (1996) Interferon-γ modulates lung macrophage production of PDGF-BB and fibroblast growth. J. Lipid Mediat. Cell Signal. 13, 89-97
7. Hermansson, M., Nistér, M., Betsholtz, C., Heldin, C. H., Westermark, B., and Funa, K. (1988) Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc. Natl. Acad. Sci. U.S.A. 85, 7748-7752
8. Tsai, J. C., Goldman, C. K., and Gillespie, G. Y. (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J. Neurosurg. 82, 864-873
9. Johnsson, A., Heldin, C. H., Westermark, B., and Wasteson, A. (1982) Platelet-derived growth factor: identification of constituent polypeptide chains. Biochem. Biophys. Res. Commun. 104, 66-74 (Pubitemid 12146288)
10. Li, X., Pontén, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Bäckström, G., Hellström, M., Boström, H., Li, H., Soriano, P., Betsholtz, C., Heldin, C. H., Alitalo, K., Ostman, A., and Eriksson, U. (2000) PDGF-C is a new protease-activated ligand for the PDGF α-receptor. Nat. Cell Biol. 2, 302-309
11. Bergsten, E., Uutela, M., Li, X., Pietras, K., Ostman, A., Heldin, C. H., Alitalo, K., and Eriksson, U. (2001) PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor. Nat. Cell Biol. 3, 512-516 (Pubitemid 32422089)
12. LaRochelle, W. J., Jeffers, M., McDonald, W. F., Chillakuru, R. A., Giese, N. A., Lokker, N. A., Sullivan, C., Boldog, F. L., Yang, M., Vernet, C., Burgess, C. E., Fernandes, E., Deegler, L. L., Rittman, B., Shimkets, J., Shimkets, R. A., Rothberg, J. M., and Lichenstein, H. S. (2001) PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 3, 517-521 (Pubitemid 32422090)
13. Gilbertson, D. G., Duff, M. E., West, J. W., Kelly, J. D., Sheppard, P. O., Hofstrand, P. D., Gao, Z., Shoemaker, K., Bukowski, T. R., Moore, M., Feldhaus, A. L., Humes, J. M., Palmer, T. E., and Hart, C. E. (2001) Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor. J. Biol. Chem. 276, 27406-27414
14. Jain, R. K., Lahdenranta, J., and Fukumura, D. (2008) Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model. PLoS Med. 5, e24
15. Gehmert, S., Gehmert, S., Prantl, L., Vykoukal, J., Alt, E., and Song, Y. H. (2010) Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/PDGFR-β signaling pathway. Biochem. Biophys. Res. Commun. 398, 601-605
16. Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867 (Pubitemid 36019639)
17. Marx, J. (2004) Cancer research. Inflammation and cancer: the link grows stronger. Science 306, 966-968
18. Leek, R. D., and Harris, A. L. (2002) Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7, 177-189 (Pubitemid 38420774)
19. Brigati, C., Noonan, D. M., Albini, A., and Benelli, R. (2002) Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19, 247-258 (Pubitemid 34553525)
20. Balkwill, F., and Mantovani, A. (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545 (Pubitemid 32173595)
21. Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., and Pollard, J. W. (2002) The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland. Biol. Neoplasia 7, 147-162 (Pubitemid 38420772)
22. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (Pubitemid 35223554)
23. Pollard, J. W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78
24. Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., and Harris, A. L. (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190, 430-436 (Pubitemid 30163582)
25. Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., and Era, S. (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol. Rep. 14, 425-431
26. Kawata, M., Koinuma, D., Ogami, T., Umezawa, K., Iwata, C., Watabe, T., and Miyazono, K. (2012) TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. J. Biochem. 151, 205-216
27. Katsuno, Y., Lamouille, S., and Derynck, R. (2013) TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 25, 76-84
28. Marconi, C., Bianchini, F., Mannini, A., Mugnai, G., Ruggieri, S., and Calorini, L. (2008) Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells. Clin. Exp. Metastasis 25, 225-231
29. Tejada, M. L., Yu, L., Dong, J., Jung, K., Meng, G., Peale, F. V., Frantz, G. D., Hall, L., Liang, X., Gerber, H. P., and Ferrara, N. (2006) Tumor-driven paracrine platelet-derived growth factor receptor α signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin. Cancer Res. 12, 2676-2688
30. Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., and Giese, N. A. (2002) Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 62, 3729-3735 (Pubitemid 34728854)
31. Andrae, J., Molander, C., Smits, A., Funa, K., and Nistér, M. (2002) Platelet-derived growth factor-B and -C and active α-receptors in medulloblastoma cells. Biochem. Biophys. Res. Commun. 296, 604-611
32. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (Pubitemid 27456390)
33. Danial, N. N. (2008) BAD: undertaker by night, candyman by day. Oncogene 27, S53-70
34. Skommer, J., Wlodkowic, D., and Deptala, A. (2007) Larger than life: Mitochondria and the Bcl-2 family. Leuk. Res. 31, 277-286 (Pubitemid 46073182)
35. Berger, N. A., and Petzold, S. J. (1985) Identification of minimal size requirements of DNA for activation of poly(ADP-ribose) polymerase. Biochemistry 24, 4352-4355 (Pubitemid 15228442)
36. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBOJ. 13, 3286-3295 (Pubitemid 24226943)
37. Romashkova, J. A., and Makarov, S. S. (1999) NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90
38. Vantler, M., Caglayan, E., Zimmermann, W. H., Bäumer, A. T., and Rosenkranz, S. (2005) Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3′-kinase is important. J. Biol. Chem. 280, 14168-14176 (Pubitemid 40517319)
39. McDonald, N. Q., and Hendrickson, W. A. (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-424 (Pubitemid 23143340)
40. Joyce, J. A., and Pollard, J. W. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252
41. Smith, H. A., and Kang, Y. (2013) The metastasis-promoting roles of tumor-associated immune cells. J. Mol. Med. 91, 411-429
42. Gocheva, V., Wang, H. W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., and Joyce, J. A. (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24, 241-255
43. Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., and Ben-Baruch, A. (2002) The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 62, 1093-1102 (Pubitemid 34160293)
44. Bingle, L., Brown, N. J., and Lewis, C. E. (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265 (Pubitemid 34189413)
45. Wei, Q., Fang, W., Ye, L., Shen, L., Zhang, X., Fei, X., Chen, X., Li, X., Xiao, J., and Ning, G. (2012) Density of tumor associated macrophage correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid. 22, 905-910
46. Tang, X., Mo, C., Wang, Y., Wei, D., and Xiao, H. (2013) Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology 138, 93-104
47. Yue, Z. Q., Liu, Y. P., Ruan, J. S., Zhou, L., and Lu, Y. (2012) Tumor-associated macrophages: a novel potential target for cancer treatment. Chin. Med. J. 125, 3305-3311
48. Weigert, A., Sekar, D., and Brüne, B. (2009) Tumor-associated macrophages as targets for tumor immunotherapy. Immunotherapy 1, 83-95
49. Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., and Mukaida, N. (2009) Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 69, 7884-7892
50. Gazzaniga, S., Bravo, A. I., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., and Wainstok, R. (2007) Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. The J. Invest. Dermatol. 127, 2031-2041 (Pubitemid 47075380)
51. Zhu, X., Fujita, M., Snyder, L. A., and Okada, H. (2011) Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. J. Neurooncol. 104, 83-92
52. Nagai, T., Tanaka, M., Tsuneyoshi, Y., Xu, B., Michie, S. A., Hasui, K., Hirano, H., Arita, K., and Matsuyama, T. (2009) Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β. Cancer Immunol. Immunother. 58, 1577-1586
53. Hiraoka, K., Zenmyo, M., Watari, K., Iguchi, H., Fotovati, A., Kimura, Y. N., Hosoi, F., Shoda, T., Nagata, K., Osada, H., Ono, M., and Kuwano, M. (2008) Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci. 99, 1595-1602
54. Tsagozis, P., Eriksson, F., and Pisa, P. (2008) Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages. Cancer Immunol. Immunother. 57, 1451-1459
55. Shime, H., Matsumoto, M., Oshiumi, H., Tanaka, S., Nakane, A., Iwakura, Y., Tahara, H., Inoue, N., and Seya, T. (2012) Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc. Natl. Acad. Sci. U.S.A. 109, 2066-2071
56. Cluff, C. W. (2010) Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. Adv. Exp. Med. Biol. 667, 111-123
57. Smith, K. J., Hamza, S., and Skelton, H. (2004) Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clin. Exp. Dermatol. 29, 505-512 (Pubitemid 39278198)
58. Edwards, J. P., and Emens, L. A. (2010) The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE(2) in murine macrophages. Int. Immunopharmacol. 10, 1220-1228
59. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., Staels, B., and Chinetti-Gbaguidi, G. (2007) PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143 (Pubitemid 47189091)
60. Xin, H., Zhang, C., Herrmann, A., Du, Y., Figlin, R., and Yu, H. (2009) Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 69, 2506-2513
61. Mantovani, A., and Sica, A. (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237
62. Coward, J., Kulbe, H., Chakravarty, P., Leader, D., Vassileva, V., Leinster, D. A., Thompson, R., Schioppa, T., Nemeth, J., Vermeulen, J., Singh, N., Avril, N., Cummings, J., Rexhepaj, E., Jirström, K., Gallagher, W. M., Brennan, D. J., McNeish, I. A., and Balkwill, F. R. (2011) Interleukin-6 as a therapeutic target in human ovarian cancer. Clin. Cancer Res. 17, 6083-6096
63. Sitohy, B., Nagy, J. A., and Dvorak, H. F. (2012) Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res. 72, 1909-1914
64. Soria, G., and Ben-Baruch, A. (2008) The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271-285
65. Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., and Pienta, K. J. (2009) CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J. Biol. Chem. 284, 34342-34354
66. Sun, P. D., and Davies, D. R. (1995) The cystine-knot growth-factor super-family. Annu. Rev. Biophys. Biomol. Struct. 24, 269-291
67. Vitt, U. A., Hsu, S. Y., and Hsueh, A. J. (2001) Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol. Endocrinol. 15, 681-694 (Pubitemid 32411309)
68. Reigstad, L. J., Varhaug, J. E., and Lillehaug, J. R. (2005) Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J. 272, 5723-5741 (Pubitemid 41689346)
69. Ding, H., Wu, X., Kim, I., Tam, P. P., Koh, G. Y., and Nagy, A. (2000) The mouse Pdgfc gene: dynamic expression in embryonic tissues during organogenesis. Mech. Dev. 96, 209-213
70. Yang, J., Liu, X., Nyland, S. B., Zhang, R., Ryland, L. K., Broeg, K., Baab, K. T., Jarbadan, N. R., Irby, R., and Loughran, T. P., Jr. (2010) Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood 115, 51-60
71. Lu, X., Masic, A., Li, Y., Shin, Y., Liu, Q., and Zhou, Y. (2010) The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1. J. Gen. Virol. 91, 1439-1449
72. Dey, J. H., Bianchi, F., Voshol, J., Bonenfant, D., Oakeley, E. J., and Hynes, N. E. (2010) Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor out-growth and metastasis. Cancer Res. 70, 4151-4162
73. Jeong, S. J., Dasgupta, A., Jung, K. J., Um, J. H., Burke, A., Park, H. U., and Brady, J. N. (2008) PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 370, 264-272 (Pubitemid 350199679)
74. Datta, S. R., Brunet, A., and Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927
75. Hu, Q., Klippel, A., Muslin, A. J., Fantl, W. J., and Williams, L. T. (1995) Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268, 100-102
76. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., and Tsichlis, P. N. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736
77. Duronio, V. (2008) The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem. J. 415, 333-344
78. Datta, S. R., Katsov, A., Hu, L., Petros, A., Fesik, S. W., Yaffe, M. B., and Greenberg, M. E. (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 6, 41-51
79. Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., Ierino, H., Lee, E. F., Fairlie, W. D., Bouillet, P., Strasser, A., Kluck, R. M., Adams, J. M., and Huang, D. C. (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856-859
80. Chipuk, J. E., Bouchier-Hayes, L., and Green, D. R. (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ. 13, 1396-1402 (Pubitemid 44057475)
81. Quan, J. H., Cha, G. H., Zhou, W., Chu, J. Q., Nishikawa, Y., and Lee, Y. H. (2013) Involvement of PI 3 kinase/Akt-dependent Bad phosphorylation in Toxoplasma gondii-mediated inhibition of host cell apoptosis. Exp. Parasitol. 133, 462-471
82. Weisser, S. B., McLarren, K. W., Voglmaier, N., van Netten-Thomas, C. J., Antov, A., Flavell, R. A., and Sly, L. M. (2011) Alternative activation of macrophages by IL-4 requires SHIP degradation. Eur. J. Immunol. 41, 1742-1753